CbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News
Leading CBD company comments on FDA declining to regulate the industry and calling on Congress to create new rulesCharlotte, North Carolina--(Newsfile Corp. - January 26, 2023) - cbdMD, Inc. (NYSE Ame
CbdMD (NYSEAMERICAN:YCBD) Stock Price Up 15.1%
cbdMD, Inc. (NYSEAMERICAN:YCBD – Get Rating)'s stock price rose 15.1% during mid-day trading on Thursday . The stock traded as high as $0.29 and last traded at $0.29. Approximately 547,954 shares wer
Key Marijuana Executive Changes You Should Know About: This Company Got A New CEO & More News
Humble & Fume Names New CEO Humble & Fume Inc. (CSE:HMBL) (OTCQX:HUMBF) has named chairman of the board Jakob Ripshtein to be its new CEO. He replaces Joel Toguri, who is stepping down to pursue other
CbdMD Welcomes Shannon Charles as Chief Marketing Officer
CBD Life Sciences, Inc. (CBDL) Launches Premium Terpene Infused Oil
CbdMD (NYSEAMERICAN:YCBD) Shares Down 3.5%
cbdMD, Inc. (NYSEAMERICAN:YCBD – Get Rating) shares were down 3.5% during trading on Thursday . The stock traded as low as $0.24 and last traded at $0.25. Approximately 119,448 shares traded hands du
CbdMD Q4 Sales $7.86M Down From $9.79M YoY
cbdMD (AMEX:YCBD) reported $7.86 million in sales this quarter. This is a 19.75 percent decrease over sales of $9.79 million the same period last year.
CbdMD Continues to Drive Operational Improvement
Earnings Scheduled For December 15, 2022
Companies Reporting Before The Bell • Trinity Biotech (NASDAQ:TRIB) is expected to report quarterly loss at $0.04 per share on revenue of $19.50 million. • Live Ventures (NASDAQ:LIVE) is likely to rep
CbdMD, Inc. to Host Conference Call to Discuss Fourth Quarter and Fiscal 2022 Results
Loading...
No Stock Yet